Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Christine Bigaillon is active.

Publication


Featured researches published by Christine Bigaillon.


Journal of Clinical Virology | 2012

Circulation of genotype 4 hepatitis E virus in Europe: First autochthonous hepatitis E infection in France

Sophie Tesse; Bruno Lioure; Luc Fornecker; Marie-Josée Wendling; Françoise Stoll-Keller; Christine Bigaillon; Elisabeth Nicand

BACKGROUND Human HEV infections reported in Europe without previous travel to endemic regions are linked to exposure to genotype 3 Hepatitis E virus (HEV).Genotype 3 is widely distributed through human cases and zoonotic reservoir. The geographical distribution of genotype 4 is limited to Asian countries. OBJECTIVES The first human case of autochthonous genotype 4 hepatitis E infection was reported in France. STUDY DESIGN The HEV infection was described in an immunosuppressed patient, presenting an acute myeloblastic leukemia. Investigation of the case was performed on detection of HEV markers in the patient and in the environment. RESULTS Hepatitis E infection was diagnosed on the basis of HEV RNA viremia, and detection of anti-HEV IgM. The prognostic of leukemia was favorable and HEV was cleared without relapsing. HEV isolate was classified into genotype 4. CONCLUSIONS The recent characterization of genotype 4 HEV through swine surveillance in Europe and the description of the first human case in France open interesting questions about the circulation of this genotype: health risks in human population, transmission patterns, and zoonotic reservoir.


Journal of Virological Methods | 2010

Use of hepatitis E IgG avidity for diagnosis of hepatitis E infection.

Christine Bigaillon; Sophie Tesse; Gisèle Lagathu; Elisabeth Nicand

The diagnosis of acute hepatitis E infection is based on the detection of HEV RNA or specific IgM in immunocompetent patients. Viraemia and excretion of HEV RNA in faeces are not observed in all patients and commercial kits vary in their performance for anti-HEV IgM detection. Additional diagnostic tests must therefore be considered. The value of anti-HEV IgG avidity index for differentiating between acute infection and previous exposure to HEV in countries of low endemicity was investigated. 132 specimens were included, with 39 serum samples from patients with known HEV infection, studied retrospectively. IgG avidity index was high (>60%) in patients with previous infection (n=16) or polyclonal activation (n=3) but was low (<40%) in patients with acute infection (n=20). Then, 93 serum samples from patients, checking for acute hepatitis (detection of anti-HEV IgM but not of HEV RNA) were investigated. IgG avidity index was <40% in 77 of these patients, consistent with acute infection. It exceeded 60% in 15 patients, providing evidence of contact with HEV up to six months previously. One patient had an uninterpretable biological profile, with an IgG avidity index between 40% and 60%. IgG mature slowly during HEV infection, over a period of six months. IgG avidity index can therefore be used to exclude primary infection. This method should improve the diagnosis of acute hepatitis E.


International Journal of Antimicrobial Agents | 2017

Clinical isolates of escherichia coli solely resistant to mecillinam: prevalence and epidemiology.

Aurore Bousquet; Sarah Bugier; Sébastien Larréché; Christine Bigaillon; Philippe Weber; Hervé Delacour; Eric Valade; Dominique De Briel; Audrey Mérens

In routine susceptibility testing of Gram-negative bacteria, a particular resistance phenotype was observed: an Escherichia coli isolate from a urine sample exhibited resistance solely to mecillinam (MEC) but was fully susceptible to other β-lactam antibiotics (MEC-R-BL-S). The objectives as this study were to determine the prevalence of this phenotype and to describe the phenotype, molecular epidemiology and genetic background. Between 1 January 2014 and 31 January 2016, MEC-R-BL-S E. coli isolates from urine were collected and genes previously reported as mostly involved in MEC resistance were analysed. The genetic relatedness among isolates was investigated by repetitive element sequence-based PCR (rep-PCR) and multilocus sequence typing (MLST). Ten MEC-R-BL-S isolates were collected, accounting for 0.4% (10/2547) of all E. coli obtained from urine samples, 0.9% (10/1135) of ampicillin-susceptible E. coli isolates and 9.6% (10/104) of MEC-R E. coli isolates. The isolates appeared as small colonies with round morphology and had impaired fitness. The isolates were not clonal and belonged to various extraintestinal or commensal E. coli phylogroups. Mutations in the cysB gene were evidenced in all clinical isolates. In conclusion, microbiologists should be aware of these isolates with a particular susceptibility phenotype, which is not due to error in disk diffusion but is a real non-enzymatic antibiotic resistance pattern.


Pathologie Biologie | 2009

Hépatite E : maladie émergente ?

Elisabeth Nicand; Christine Bigaillon; Sophie Tesse


Journal of Infection | 2007

Acute bilateral uveitis associated with an active human herpesvirus-6 infection

Jérôme Maslin; Christine Bigaillon; Françoise Froussard; Vincent Enouf; Elisabeth Nicand


International Journal of Antimicrobial Agents | 2008

Etest for antibiotic susceptibility testing of Bacillus anthracis, Bacillus cereus and Bacillus thuringiensis: evaluation of a French collection.

Audrey Mérens; Josée Vaissaire; Jean-Didier Cavallo; C. Le Doujet; C. Gros; Christine Bigaillon; Jean-Charles Paucod; F. Berger; Eric Valade; Dominique R. Vidal


The Journal of Infectious Diseases | 2016

Deployment of the French Military Field Laboratory Dedicated to Ebola Virus Infected Patients in Guinea, January–July 2015

Frédéric Janvier; Vincent Foissaud; Déborah Delaune; Olivier Flusin; Philippe Dubrous; Christine Mac Nab; Tiphaine Gaillard; Pascale Perez; Thomas Poyot; Jean-Charles Paucod; Stéphane Richard; Olivier Ferraris; Hervé Delacour; Christine Bigaillon; Isabelle Leparc-Goffard; Christophe N. Peyrefitte; Brisou Patrick; Christophe Renard; Eric Garnotel; Jean-Louis Koeck; François M. Thibault; Eric Valade; Audrey Mérens


Presse Medicale | 2009

Hépatite E initialement séronégative et d’évolution prolongée chez un malade traité pour un lymphome

Laurence Ollier; Christine Bigaillon; Nathalie Tieulie; Sophie Tesse; Heudier P; Frédérick Sanderson; Valérie Giordanengo; Elisabeth Nicand; Jean-Gabriel Fuzibet


Medecine Et Maladies Infectieuses | 2018

Microbiology of French military casualties repatriated from overseas for an open traumatic injury

Sébastien Larréché; Aurore Bousquet; C. Soler; C. Mac Nab; D. De Briel; Déborah Delaune; Christine Bigaillon; P. Pasquier; C. Dubost; Thomas Demoures; B. Malgras; S. Ausset; S. de Rudnicki; T. Leclerc; B. de Loynes; S. Bonnet; N. Mocellin; C. Ficko; R. Haus; O. Hersan; Sylvain Rigal; Audrey Mérens


Annales De Biologie Clinique | 2017

Mycoplasma genitalium : un mycoplasme encore sous-estimé

Julie Plantamura; Christine Bigaillon; Aurore Bousquet; Déborah Delaune; Sébastien Larréché; Sarah Bugier; Audrey Mérens; Cécile Ficko

Collaboration


Dive into the Christine Bigaillon's collaboration.

Top Co-Authors

Avatar

Audrey Mérens

Pierre-and-Marie-Curie University

View shared research outputs
Top Co-Authors

Avatar

Eric Valade

École Normale Supérieure

View shared research outputs
Top Co-Authors

Avatar

Hervé Delacour

École Normale Supérieure

View shared research outputs
Top Co-Authors

Avatar

B. Malgras

École Normale Supérieure

View shared research outputs
Top Co-Authors

Avatar

Bruno Lioure

University of Strasbourg

View shared research outputs
Top Co-Authors

Avatar

Christophe Renard

École Normale Supérieure

View shared research outputs
Top Co-Authors

Avatar

Eric Garnotel

École Normale Supérieure

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge